Ryan Specialty (NYSE:RYAN – Get Free Report) had its price objective lowered by stock analysts at Keefe, Bruyette & Woods from $77.00 to $76.00 in a report issued on Friday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Keefe, Bruyette & Woods’ target price points to a potential upside of 10.62% from the stock’s previous close.
A number of other analysts have also recently commented on RYAN. Morgan Stanley assumed coverage on shares of Ryan Specialty in a report on Thursday, December 5th. They set an “overweight” rating and a $90.00 target price for the company. Wells Fargo & Company reduced their price objective on Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 14th. Finally, Barclays raised their target price on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, November 21st. One research analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, Ryan Specialty currently has an average rating of “Hold” and an average price target of $74.30.
Get Our Latest Stock Analysis on Ryan Specialty
Ryan Specialty Stock Performance
Ryan Specialty (NYSE:RYAN – Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. On average, equities analysts forecast that Ryan Specialty will post 1.82 earnings per share for the current year.
Insiders Place Their Bets
In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 35,000 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $66.71, for a total value of $2,334,850.00. Following the completion of the transaction, the director now directly owns 60,200 shares in the company, valued at $4,015,942. This represents a 36.76 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In the last quarter, insiders sold 316,451 shares of company stock worth $20,907,793. Corporate insiders own 11.10% of the company’s stock.
Institutional Investors Weigh In On Ryan Specialty
Several institutional investors and hedge funds have recently modified their holdings of the stock. Signaturefd LLC grew its stake in Ryan Specialty by 12.3% during the third quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock valued at $89,000 after acquiring an additional 148 shares in the last quarter. Mariner LLC boosted its holdings in shares of Ryan Specialty by 3.4% during the 4th quarter. Mariner LLC now owns 5,278 shares of the company’s stock valued at $339,000 after purchasing an additional 172 shares during the last quarter. Sanctuary Advisors LLC grew its position in shares of Ryan Specialty by 1.2% during the fourth quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company’s stock valued at $1,045,000 after purchasing an additional 188 shares in the last quarter. State of Alaska Department of Revenue increased its holdings in shares of Ryan Specialty by 1.6% in the fourth quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company’s stock worth $778,000 after purchasing an additional 190 shares during the last quarter. Finally, CIBC Asset Management Inc lifted its position in shares of Ryan Specialty by 5.6% in the fourth quarter. CIBC Asset Management Inc now owns 3,674 shares of the company’s stock worth $236,000 after buying an additional 196 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.
Ryan Specialty Company Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Read More
- Five stocks we like better than Ryan Specialty
- How to Invest in the FAANG Stocks
- Palantir Stock Skids—How Much Further Can It Fall?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite?
- What is diluted earnings per share (Diluted EPS)?
- 2 S&P 500 ETFs for Growth and Leverage in a Hot Market
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.